Patents by Inventor Lewis Strauss

Lewis Strauss has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antineoplastic combinations of CCI-779 and rituximab
    Publication number: 20050272758
    Abstract: This invention provides the use of a combination of CCI-779 and rituximab in the treatment of non-Hodgkin's lymphoma.
    Type: Application
    Filed: March 9, 2005
    Publication date: December 8, 2005
    Applicant: Wyeth
    Inventors: Eliel Bayever, Laurence Moore, Matthew Sherman, Lee Allen, Lewis Strauss
  • Selective treatment of IL-13 expressing tumors
    Publication number: 20050002918
    Abstract: A method of treating tumors that express a receptor for IL-13 is disclosed. The method involves directly introducing into the tumor a cytotoxin that targets the IL-13 receptor. The cytotoxic agent can be introduced by convection-enhanced delivery through a suitable catheter or by other means. Where a convection-enhanced catheter is employed, the method involves positioning the tip of a catheter at least in close proximity to the tumor. After the catheter is positioned, it is connected to a pump which delivers the active agent through the catheter tip to the tumor. A pressure gradient from the tip of the catheter is maintained during infusion.
    Type: Application
    Filed: May 10, 2004
    Publication date: January 6, 2005
    Applicants: NeoPharm, Inc., Gov't of the U.S.A., rep. by the Secretary, Dept. of Health & Human Srvces.
    Inventors: Lewis Strauss, Raj Puri